Media & Resources

In The News

An early-stage HIV vaccine is showing positive results. If it works, it would be first successful HIV vaccine after almost 40 years of research.

Business Insider

December 1, 2022

In The News

Vaccine prompts HIV antibodies in 97 per cent of people in small study

New Scientist

December 1, 2022

Scientific Publications

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay

IAVI Report

Momentum against malaria

November 29, 2022

Two vaccines are poised for delivery against this old foe. What will it take for them to change the field?

Features

Meet the IAVI scientist applying her skills to decipher how local HIV circulating strains are evolving within India and how this landscape affects applicability of prevention products for and by LMICs

November 28, 2022

Jyoti Sutar, Ph.D., senior research associate, Antibody Translational Research Program (previously the HIV Vaccine Translational Research Laboratory)

Features

Laying the groundwork for success: TB vaccine highlights at the Union

November 21, 2022

We must plan for their introduction and demand what is needed for new TB vaccines to reach End TB targets, experts say.

In The News

‘Ebola is real’: Uganda to trial vaccines and shut schools early to contain outbreak

CNN

November 18, 2022

Features

Meet the IAVI scientist who leads the team that is the first from an LMIC to report potent monoclonal neutralizing antibodies against SARS-CoV-2

November 17, 2022

Jayanta Bhattacharya, Ph.D., director, Antibody Translational Research Program and principal investigator, Translational Health Science and Technology Institute

1…28 293031 32…218 of 218

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

An early-stage HIV vaccine is showing positive results. If it works, it would be first successful HIV vaccine after almost 40 years of research.

Vaccine prompts HIV antibodies in 97 per cent of people in small study

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay

Momentum against malaria

Meet the IAVI scientist applying her skills to decipher how local HIV circulating strains are evolving within India and how this landscape affects applicability of prevention products for and by LMICs

Laying the groundwork for success: TB vaccine highlights at the Union

‘Ebola is real’: Uganda to trial vaccines and shut schools early to contain outbreak

Meet the IAVI scientist who leads the team that is the first from an LMIC to report potent monoclonal neutralizing antibodies against SARS-CoV-2

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

An early-stage HIV vaccine is showing positive results. If it works, it would be first successful HIV vaccine after almost 40 years of research.

Vaccine prompts HIV antibodies in 97 per cent of people in small study

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay

Momentum against malaria

Meet the IAVI scientist applying her skills to decipher how local HIV circulating strains are evolving within India and how this landscape affects applicability of prevention products for and by LMICs

Laying the groundwork for success: TB vaccine highlights at the Union

‘Ebola is real’: Uganda to trial vaccines and shut schools early to contain outbreak

Meet the IAVI scientist who leads the team that is the first from an LMIC to report potent monoclonal neutralizing antibodies against SARS-CoV-2

Subscription Type